PT - JOURNAL ARTICLE AU - Gordon, Debra ED - Berwanger, Otavio TI - ACT Trial Results Should Change Clinical Practice DP - 2010 01 TA - MD Conference Express PG - 16--17 VI - 10 IP - 10 4099 - http://mdc.sagepub.com/content/10/10/16.short 4100 - http://mdc.sagepub.com/content/10/10/16.full AB - Based on the results of the Acetylcysteine for the prevention of Contrast-Induced nephropathy [ACT; NCT00736866] trial, there is no evidence that the antioxidant N-acetylcysteine reduces the risk of contrast-induced nephropathy in patients who are undergoing coronary and vascular angiography.